Registers 28 Million Shares for Resale Under $50M Equity Line of Credit, Enabling Massive Dilution

summarizeSummary

Healthcare Triangle has filed an S-3 registration statement to allow a selling stockholder to resell up to 28 million shares of common stock, enabling the execution of a previously announced $50 million Equity Line of Credit agreement.

check_boxKey Events · Financing and Capital Events · HCTI

• Shares Registered for Resale

  Healthcare Triangle, Inc. has registered 28,000,000 shares of common stock for resale by Hudson Global Ventures, LLC, the selling stockholder.

• Enables $50 Million Equity Line of Credit (ELOC)

  These shares are tied to an Equity Purchase Agreement (ELOC) dated June 12, 2026, which allows the company to sell up to $50 million in shares to Hudson Global Ventures, LLC over a 36-month period.

• Significant Potential Dilution

  The potential issuance of 28 million shares represents approximately 1380% dilution to the 2,027,783 shares currently outstanding, indicating a substantial increase in the share count if fully utilized.

• Discounted Share Sales

  Shares sold under the ELOC will be priced at a discount, specifically 94% of the average of the three lowest traded prices during the five trading days preceding a put notice.

auto_awesomeAnalysis · HCTI · Technology

This S-3 filing registers 28 million shares of common stock for resale by Hudson Global Ventures, LLC, the investor in the previously announced $50 million Equity Line of Credit (ELOC) agreement from June 12, 2026. While the ELOC itself was disclosed in a prior 8-K, this registration is a critical procedural step that enables the investor to resell shares acquired from the company. The potential issuance of these 28 million shares represents over 1300% dilution to the current outstanding share count, indicating a substantial and ongoing dilutive capital raise for the company.